~~<i id='517AF43391'><strike id='517AF43391'><tt id='517AF43391'><pre id='517AF43391'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

fashion

author：hotspot 2025-09-05 11:16:25 - browse：4

A drug developed by the biotech firm BridgeBio to treat an increasingly common heart condition succeeded in its main goal in a clinical trial, the company said Monday, and also pointed to potential reductions in hospitalization and death.

The results may give the medicine, acoramidis, a path to the market after a failure that led its maker’s stock to plunge in December 2021.

In the time since the initial failure, a rival Pfizer drug has become even more entrenched and another medicine, from Alnylam Pharmaceuticals, has had a successful clinical readout in the heart disease, known as ATTR-CM, in which a defective protein leads clumps to build up in the heart.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

explore

focus

Wikipedia

focus

Wikipedia

AdobeIntheUnitedStates,healthcarecostsaresooutofcontrolthatmedicalcrowdfundinghasbecomecommonplace.T

WSS

Nearly two

Crowdfunding for medical bills sidesteps core problem, author says

Sepsis can kill a child within hours. Here's how hospitals are fighting back

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

OTC birth control: A brief history of over the counter pill design

Wikipedia

fashion

explore

Apple is now the first public company to be valued at $3 trillion

Sepsis can kill a child within hours. Here's how hospitals are fighting back

Affirmative action in medical school literally saved lives

Class action alleges UnitedHealth concealed DOJ probe

Guidelines to prevent youth baseball injuries need more muscle

Chemotherapy before breast cancer surgery might fuel metastasis

After affirmative action ruling, medical educators look to 'holistic review'

What Henrietta Lacks settlement says about racism in medicine

After affirmative action ruling, medical educators look to 'holistic review'

Deliver public health messages at the right time

focus

Verily hires former Apple Health leader as chief scientific officer

The effects of a landmark ruling on DNA ownership are becoming clearer

Crowdfunding for medical bills sidesteps core problem, author says

Is it ever OK for doctors to lie to their patients?

Sepsis can kill a child within hours. Here's how hospitals are fighting back

For BCIs, commercial hurdles may be bigger than scientific ones

focus

Wikipedia

focus

Wikipedia